Sicriptin 5mg Tablet
By Sicriptin
Rx
10 Tablet in a Strip

Composition
Bromocriptine(5mg)

Manufacturer - Serum Institute Of India Ltd
212/2, Hadapsar, Off Soli Poonawalla Road, Pune 411028 India

Expires on or after
August, 2025

liver
Limited information is available regarding the use of Sicriptin 5mg Tablet in individuals with liver disease. It is recommended to consult with your doctor before using this medication. Caution should be exercised when using Sicriptin 5mg Tablet in patients with liver issues. It is advisable to be cautious while using this medicine in such cases.

kidney
Limited data suggests Sicriptin 5mg Tablet is safe for patients with kidney disease. Dose adjustment may not be required. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Sicriptin 5mg Tablet.

driving
Caution should be taken while driving when using Sicriptin 5mg Tablet as it may lead to dizziness or weakness from low blood pressure, affecting focus and reaction time. Avoid driving if these symptoms are experienced.

pregnancy
During pregnancy, Sicriptin 5mg Tablet is considered generally safe based on animal studies with minimal adverse effects on the baby. Limited human studies are available.

breastfeeding
Sicriptin 5mg Tablet is likely unsafe to use while breastfeeding. Limited evidence indicates it may enter breastmilk and harm the baby. It is generally avoided during breastfeeding due to its lactation-suppressing effects.
Habit Forming | No |
Chemical Class | Ergolines |
Therapeutic Class | NEURO CNS |
Action Class | Dopamine agonists-Hyperprolactinemia |
₹128.08
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025